[Treatment and outcome of 14 children with hepatoblastoma].
OBJECTIVE
To assess the outcome of childhood hepatoblastoma after a combination therapy of resection and chemotherapy.


METHODS
The clinical data of 14 children with hepatoblastoma was retrospectively reviewed. Their long-term survival was followed-up.


RESULTS
Twelve cases received surgery and planned chemotherapy. The follow-up duration averaged 18 months (range 1.5-74 months). Nine survived free of events, 1 died, 1 survived with multiple lung metastases, and 1 with increased alpha-fetoprotein (AFP) content but without residual tumor.


CONCLUSIONS
Surgery assisted with chemotherapy can improve the outcome of hepatoblastoma.
Wei
Ting
T
Department of Pediatric Surgery, First Affiliated Hospital of Guangxi Medical University, Nanning, China. weitingabc123@yahoo.com.cn
Yang
Ti-Quan
TQ
Luo
Yi-Ge
YG
Dong
Chun-Qiang
CQ
D016461:Chemoembolization, Therapeutic; D002648:Child; D002675:Child, Preschool; D003131:Combined Modality Therapy; D005260:Female; D018197:Hepatoblastoma / Q000097:blood / Q000628:therapy*; D006801:Humans; D007223:Infant; D008175:Lung Neoplasms / Q000097:blood / Q000628:therapy*; D008297:Male; D012189:Retrospective Studies; D016896:Treatment Outcome; D000509:alpha-Fetoproteins / Q000032:analysis
D000509:alpha-Fetoproteins